Research Article|Articles in Press

Is modified Carnoy’s solution as effective as Carnoy’s solution in terms of amount of bone necrosis and depth of penetration?


      Carnoy’s solution, a chemical cauterisation agent, has been indicated as one of the adjuvant treatment modalities for odontogenic keratocyst. In 2000, after the ban of chloroform many surgeons adopted the use of Modified Carnoy’s solution. The purpose of this study is to compare the depth of penetration and amount of bone necrosis of Carnoy’s versus Modified Carnoy’s solution on the mandible of Wistar rats at different time intervals. Twenty-six male Wistar rats of six to eight weeks old, weighing approximately 150–200 grams, were allocated for this study. The predictor variables were type of solution and application time. The outcome variable was depth of penetration and amount of bone necrosis. Carnoy’s solution was applied on the defect on the right side of the mandible and Modified Carnoy’s solution on the left side for five minutes on eight rats, eight minutes on eight rats, and 10 minutes on eight rats. All specimens were subjected to histomorphometric analysis done using Mia image AR software. Univariate ANOVA test, and paired sample t test was done to compare the results. The depth of penetration for Carnoy’s solution was more than Modified Carnoy’s solution in the three different exposure times. Statistically significant results were observed at five minutes and eight minutes. The amount of bone necrosis was more in Modified Carnoy’s solution. The results were not statistically significant at the three different exposure times. To conclude, when one wants to use Modified Carnoy’s solution, the minimum exposure time should be 10 minutes to achieve similar results as those of Carnoy’s solution.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to British Journal of Oral and Maxillofacial Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Slootweg P.J.
        Lesions of the jaws.
        Histopathology. 2009; 54: 401-418
        • Pitak-Arnnop P.
        • Chaine A.
        • Oprean N.
        • et al.
        Management of odontogenic keratocysts of the jaws: A ten-year experience with 120 consecutive lesions.
        J Craniomaxillofac Surg. 2010; 38: 358-364
        • Shear M.
        The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 1. Clinical and early experimental evidence of aggressive behaviour.
        Oral Oncol. 2002; 38: 219-226
        • Stoelinga P.J.
        Long-term follow-up on keratocysts treated according to a defined protocol.
        Int J Oral Maxillofac Surg. 2001; 30: 14-25
        • Antonoglou G.N.
        • Sándor G.K.
        • Koidou V.P.
        • et al.
        Non-syndromic and syndromic keratocystic odontogenic tumors: systematic review and meta-analysis of recurrences.
        J Craniomaxillofac Surg. 2014; 42: e364-e371
        • Sharif F.N.
        • Oliver R.
        • Sweet C.
        • et al.
        Interventions for the treatment of keratocystic odontogenic tumours (KCOT, odontogenic keratocysts (OKC)).
        Cochrane Database Syst Rev. 2010; 9: CD008464
        • Al-Moraissi E.A.
        • Dahan A.A.
        • Alwadeai M.S.
        • et al.
        What surgical treatment has the lowest recurrence rate following the management of keratocystic odontogenic tumor? A large systematic review and meta-analysis.
        J Craniomaxillofac Surg. 2017; 45: 131-144
        • Pereira M.A.
        • Dias A.R.
        • Faraj S.F.
        • et al.
        Carnoy’s solution is an adequate tissue fixative for routine surgical pathology, preserving cell morphology and molecular integrity.
        Histopathology. 2015; 66: 388-397
        • Cutler E.C.
        • Zollinger R.
        The use of sclerosing solutions in the treatment of cysts and fistulae.
        Am J Surg. 1933; 19: 411-418
        • Voorsmit R.A.
        • Stoelinga P.J.
        • van Haelst U.J.
        The management of keratocysts.
        J Maxillofac Surg. 1981; 9: 228-236
        • Pogrel M.A.
        The keratocystic odontogenic tumor.
        Oral Maxillofac Surg Clin North Am. 2013; 25: 21-30
        • Stoelinga P.J.
        The treatment of odontogenic keratocysts by excision of the overlying, attached mucosa, enucleation, and treatment of the bony defect with carnoy solution.
        J Oral Maxillofac Surg. 2005; 63: 1662-1666
        • Johnson N.R.
        • Batstone M.D.
        • Savage N.W.
        Management and recurrence of keratocystic odontogenic tumor: a systematic review.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2013; 116: e271-e276
        • Alchalabi N.J.
        • Merza A.M.
        • Issa S.A.
        Using Carnoy’s solution in treatment of keratocystic odontogenic tumor.
        Ann Maxillofac Surg. 2017; 7: 51-56
        • Lal B.
        • Kumar R.D.
        • Alagarsamy R.
        • A.
        • et al.
        Role of Carnoy’s solution as treatment adjunct in jaw lesions other than odontogenic keratocyst: a systematic review.
        Br J Oral Maxillofac Surg. 2021; 59: 729-741
        • Voorsmit R.A.
        The incredible keratocyst: a new approach to treatment.
        Deutsch Zahnarztl Z. 1985; 40: e641-e644
      1. FDA. US food and Drug administration sec.460.200. FDA compliance policy. 1992 Document citation: 67 FR 39409.

        • Donnelly L.A.
        • Simmons T.H.
        • Blitstein B.J.
        • et al.
        Modified Carnoy’s compared to Carnoy’s solution is equally effective in preventing recurrence of odontogenic keratocysts.
        J Oral Maxillofac Surg. 2021; 79: 1874-1881
        • Stoelinga P.J.
        • Peters J.H.
        A note on the origin of keratocysts of the jaws.
        Int J Oral Surg. 1973; 2: 37-44
        • Carvalho F.S.
        • Feitosa V.P.
        • Fonseca S.G.
        • et al.
        Physicochemical and rheological characterization of different Carnoy & apos;s solutions applied in oral and maxillofacial surgery.
        J Raman Spectrosc. 2017; 48: 1375-1384
        • Ecker J.
        • Horst R.
        • Koslovsky D.
        Current role of Carnoy’s solution in treating keratocystic odontogenic tumors.
        J Oral Maxillofac Surg. 2016; 74: 278-282
        • Dashow J.E.
        • McHugh J.B.
        • Braun T.M.
        • et al.
        Significantly decreased recurrence rates in keratocystic odontogenic tumor with simple enucleation and curettage using Carnoy’s versus modified Carnoy’s solution.
        J Oral Maxillofac Surg. 2015; 73: 2132-2135
        • Donnelly L.A.
        • Simmons T.H.
        • Blitstein B.J.
        • et al.
        Modified Carnoy’s compared to Carnoy’s solution is equally effective in preventing recurrence of odontogenic keratocysts.
        J Oral Maxillofac Surg. 2021; 79: 1874-1881
        • Carvalho F.S.
        • Verde M.M.
        • Viana K.F.
        • et al.
        Pharmacological characterization and Raman spectroscopy evaluation of oral and maxillofacial surgery-related Carnoy’s solution modified by different viscosity agents.
        Asian Pac J Cancer Prev. 2019; 20: 3335-3339
        • Carvalho F.S.
        • Feitosa V.P.
        • Silva P.G.
        • et al.
        Evaluation of different therapeutic Carnoy’s formulations on hard human tissues: a Raman microspectroscopy, microhardness, and scanning electron microscopy study.
        J Craniomaxillofac Surg. 2018; 46: 749-758
        • Hellstein J.W.
        • Hopkins T.
        • Morgan T.A.
        The history and mystery of Carnoy solution: an assessment of the need for chloroform.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007; 103: 117-123
        • Hellner D.
        • Schmelzle R.
        • Lierse W.
        • et al.
        Injury of the inferior alveolar nerve due to Carnoy’s solution.
        Dtsch Z Mund Kiefer Gesichts Chir. 1990; 14 (paper in German): 375-377
        • Frerich B.
        • Cornelius C.P.
        • Wiethölter H.
        Critical time of exposure of the rabbit inferior alveolar nerve to Carnoy’s solution.
        J Oral Maxillofac Surg. 1994; 52: 599-606
        • Saulacic N.
        • Stajcic Z.
        • Stojcev Stajcic L.
        • et al.
        Effects of Carnoy’s solution on blood vessels of the axillary fossa of rats.
        Int J Oral Maxillofac Surg. 2009; 38: 876-879
        • da Silva Y.S.
        • Stoelinga P.
        • Naclério-Homem
        Immediate and late effects of Carnoy’s solution on the mandibular bone of Wistar rats.
        Oral Surg. 2018; 12: 104-109